Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 788.45B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Celgene (CELG) , Gilead Sciences (GILD).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Anika Therapeutics (ANIK)
4.3/5 702.1M 22.87 3.1% -8.53%
Amgen (AMGN)
4.3/5 132.53B 17.20 1.58% 8.78%
Gilead Sciences (GILD)
4.2/5 96.38B 7.86 3.67% -14.78%
Biogen Inc (BIIB)
4.1/5 60.44B 17.85 0.1% -1.69%
Cambrex (CBM)
4.1/5 1.92B 22.61 0.77% 2.29%
PDL BioPharma (PDLI)
4.0/5 381.53M 26.44 -0.84% -32.67%
Emergent Biosolutions (EBS)
4.0/5 1.47B 33.28 5.31% 11.04%
Celgene (CELG)
4.0/5 107.55B 52.02 2.13% 28.11%
China Biologic Products (CBPO)
3.9/5 2.8B 26.64 0.28% -7.09%
Innoviva (INVA)
3.9/5 1.43B 21.77 1.56% 13.66%
Regeneron Pharma (REGN)
3.9/5 54.84B 62.72 3.58% 31.83%
Enzo Biochem (ENZ)
3.7/5 526.72M 15.74 -3.24% 73.55%
Alexion Pharma (ALXN)
3.7/5 29.59B 62.56 4.78% 4.76%
Myriad Genetics (MYGN)
3.7/5 1.65B 53.69 -2.19% -24.43%
Illumina (ILMN)
3.7/5 25.22B 34.45 0.59% 14.59%
Repligen (RGEN)
3.6/5 1.45B 112.45 1.34% 54.36%
BioTechne Corporation (TECH)
3.5/5 4.4B 63.51 1.64% 6.53%
ANI Pharma (ANIP)
3.5/5 564.81M 147.73 1.93% -17.34%
Heska (HSKA)
3.4/5 712.81M 55.13 -2.3% 136.47%
MiMedx (MDXG)
3.4/5 1.65B 107.21 -3.32% 90.75%
VIVUS (VVUS)
3.3/5 130.92M 3.64 -0.8% 6.9%
Integra LifeSciences (IART)
3.3/5 4.16B 65.70 -0.13% 39.25%
Qiagen (QGEN)
3.3/5 7.81B 96.19 0.93% 44.31%
AMAG Pharma (AMAG)
3.2/5 676.38M - -3.02% -25.4%
Osiris Therapeutics (OSIR) 3.1/5 240.3M 78.00 1.46% 35.67%
Ligand Pharma (LGND)
2.9/5 2.58B - 5.4% -7.17%
Horizon Pharma (HZNP)
2.9/5 2.09B - 0.55% -31.76%
Momenta Pharma (MNTA)
2.8/5 1.25B - -1.47% 47.24%
Bio-Rad Labs (BIO.B)
2.8/5 6.96B 250.05 4.7% 63.72%
Vertex Pharma (VRTX)
2.8/5 40.64B 240.74 26.28% 73.79%
Incyte (INCY)
2.7/5 27.48B - 2.76% 55.33%
Cytokinetics (CYTK)
2.7/5 705.82M - 4.32% 47.21%
NeoGenomics (NEO)
2.6/5 721.85M - -1.41% -2.15%
Exelixis (EXEL)
2.6/5 7.97B - 3.89% 213.71%
Genomic Health (GHDX)
2.5/5 1.13B - -0.33% 16.81%
Retrophin (RTRX)
2.5/5 755.83M - 3.02% 9.27%
Galapagos (GLPG)
2.4/5 4.18B 1619.60 8.7% 55.48%
Vanda Pharmaceuticals (VNDA)
2.4/5 730.66M - 0 46.3
Sinovac Biotech (SVA)
2.4/5 390.58M - 0 14.93
Alkermes (ALKS)
2.4/5 8.84B - -3.23% 15.92%
Seattle Genetics (SGEN)
2.4/5 7.76B - 1.23% 23.64%
EXACT Sciences (EXAS)
2.3/5 4.63B - 1.37% 213.86%
Acorda Therapeutics (ACOR)
2.3/5 963.52M - 1.72% -19.34%
BioMarin Pharma (BMRN)
2.3/5 15.58B - 2.64% -4.59%
Editas (EDIT)
2.3/5 654.13M - -2.83% -41.65%
Pieris Pharma (PIRS)
2.2/5 245.49M - -0.7% 237.28%
Organovo (ONVO)
2.2/5 250.34M - -7.06% -41.63%
Mesoblast (MESO)
2.2/5 659.9M - 1.31% 81.84%
Array BioPharma (ARRY)
2.2/5 1.41B - -3.17% 127.62%
MyoKardia (MYOK)
2.2/5 427.8M - -1.81% -12.65%
Geron (GERN)
2.2/5 445.69M - -2.1% 5.26%
Kamada (KMDA)
2.1/5 202.29M - -3.48% 44.16%
Keryx Biopharma (KERX)
2.1/5 785.3M - -7.06% -2.43%
Intellia Therapeutics (NTLA)
2.1/5 591.24M - -1.26% -11.3%
Amarin (AMRN)
2.1/5 1.13B - -3.03% 77.02%
Arna Pharma (ARNA)
2.1/5 764.19M - -0.04% 43.15%
Intercept Pharma (ICPT)
2.1/5 3.19B - 1.92% -19.47%
Lexicon Pharma (LXRX)
2.0/5 1.76B - 4.9% 6.03%
Cellectis (CLLS)
2.0/5 950.2M - -4.01% 6.43%
Regenxbio (RGNX)
2.0/5 588.69M - -3.29% 141.16%
Halozyme Therapeutics (HALO)
2.0/5 1.89B - 2.07% 46.43%
Acadia Pharma (ACAD)
1.9/5 3.71B - 5.48% -16.74%
Blueprint Medicines (BPMC)
1.9/5 2.13B - 3.18% 154.45%
Curis (CRIS)
1.9/5 286.11M - -7.01% 25.16%
Alnylam Pharma (ALNY)
1.9/5 7.5B - 5.49% 25.24%
Agenus (AGEN)
1.9/5 500.55M - 9.78% 5.65%
Idera Pharma (IDRA)
1.9/5 280.4M - 2.17% 12.57%
Fortress Biotech (FBIO)
1.9/5 245.12M - 4.51% 61.79%
Spark Therapeutics (ONCE)
1.9/5 2.15B - 13.8% 26.23%
Kite Pharma (KITE)
1.9/5 6.17B - 6.74% 115.07%
Juno Therapeutics (JUNO)
1.8/5 3.15B - 8.71% 1.92%
Acceleron Pharma (XLRN)
1.8/5 1.21B - -0.16% -5.92%
Celldex Therapeutics (CLDX)
1.8/5 295.25M - -1.67% -50.21%
Evogene (EVGN) 1.8/5 134.27M - -5.95% -16.88%
CytomX Therapeutics (CTMX)
1.8/5 499.06M - -11.42% 29.33%
Five Prime Therapeutics (FPRX)
1.8/5 859.26M - 0.44% -36.97%
Aduro BioTech (ADRO)
1.8/5 961.31M - 4.96% -1.79%
Peregrine Pharma (PPHM)
1.8/5 207.32M - -11.71% 72.54%
Inovio Pharma (INO)
1.8/5 466.58M - -22.65% -34.17%
Immunomedics (IMMU)
1.8/5 955.18M - -4.1% 223.13%
Nymox Pharmaceutical (NYMX)
1.7/5 202.81M - 1.77% 1.26%
AVEO Pharmaceuticals (AVEO)
1.7/5 273.7M - -0.8% 143.14%
Abeona Therapeutics (ABEO)
1.7/5 394.5M - 10.11% 292%
Arbutus Biopharma (ABUS)
1.7/5 209.09M - 0 -9.52
Compugen (CGEN)
1.7/5 181.52M - -4.05% -46.13%
Uniquire (QURE)
1.7/5 208.93M - 26.39% 14.23%
bluebird bio (BLUE)
1.7/5 4.3B - 1.21% 94.79%
Stemline Therapeutics (STML)
1.7/5 256.18M - 0 40.11
Dynavax Technologies (DVAX)
1.7/5 525.58M - -2.04% -37.34%
Adverum (ADVM) 1.7/5 113.6M - -1.85% -17.96%
ZIOPHARM Oncology (ZIOP)
1.6/5 866.75M - 4.1% 35.86%
The Medicines Company (MDCO)
1.6/5 2.85B - 3.05% 12.1%
SANGAMO THERAP (SGMO)
1.6/5 683.42M - 1.06% 64.64%
Adaptimmune Therapeutics (ADAP)
1.6/5 403.54M - 1.06% -24.8%
Achillion Pharma (ACHN)
1.6/5 561.93M - -6.8% -52.21%
Prothena (PRTA)
1.6/5 2.56B - 4.01% 26.46%
Wave Life Sciences (WVE)
1.5/5 521.35M - 13.94% -10.9%
NewLink Genetics (NLNK)
1.5/5 212.18M - -1.49% -34.18%
Merrimack Pharma (MACK)
1.5/5 171.24M - -1.53% -76.55%
Reata Pharma (RETA)
1.4/5 459.3M - -0.99% 85.01%
Novavax (NVAX)
1.4/5 402.48M - 29.82% -79.86%
NantKwest (NK)
1.4/5 585.77M - 4.55% 11.23%
Revance (RVNC)
1.4/5 718.99M - 3.04% 75.15%
Merus (MRUS)
1.4/5 316.08M - -0.49% 92.22%
Coherus Biosciences (CHRS)
1.4/5 700.08M - 3.02% -43.64%
MediciNova (MNOV)
1.4/5 187.55M - 4.62% -16.2%
Vtv Therapeutics (VTVT)
1.4/5 154.22M - -2.29% -15.77%
Amicus Therapeutics (FOLD)
1.4/5 2.18B - 4.8% 125.5%
MIRAGEN THERAP (MGEN)
1.4/5 306.76M - -5.41% 91.17%
Ascendis Pharma (ASND)
1.4/5 911.7M - 0.94% 116.77%
Cara Therapeutics (CARA)
1.4/5 498.99M - -0.52% 152.05%
Beigene (BGNE)
1.4/5 3.09B - 2.24% 183.11%
Syndax Pharma (SNDX)
1.3/5 304.41M - 3.75% 11.16%
KADMON HOLDINGS (KDMN)
1.3/5 148.8M - -5.9% -67.93%
OncoMed Pharma (OMED)
1.3/5 134.32M - 2% -70.69%
Epizyme (EPZM)
1.3/5 779.08M - -5.99% 32.97%
Clearside Biomedical (CLSD)
1.3/5 251.23M - 3.22% 50.68%
Fate Therapeutics (FATE)
1.3/5 127.93M - 1.64% 81.76%
Seres Therapeutics (MCRB)
1.3/5 554.97M - 19.9% -60.14%
Intra-Cellular Therapies (ITCI)
1.2/5 546.23M - 1.45% -69.54%
Selecta Biosciences (SELB)
1.2/5 327.48M - -8.67% 25.49%
Alder BioPharma (ALDR)
1.2/5 752.22M - -2.95% -57.5%
Insmed (INSM)
1.2/5 1.07B - 0.93% 56.51%
Advaxis (ADXS)
1.2/5 278.38M - -0.29% -12.24%
Paratek Pharma (PRTK)
1.2/5 586.82M - -14.43% 65.25%
Trevena (TRVN)
1.1/5 160.62M - -4.67% -58.76%
Sarepta Therapeutics (SRPT)
1.1/5 2.39B - 24.21% 81.71%
Asterias Biotherapeutics (AST) - 169.96M - -1.43% 16.16%
Igene Biotechnology (IGNE) - 0.31M - 0 0
Tengion (TNGNQ) - 0.02M - 0 0
Bionovo (BNVIQ) - 0.02M - N/A N/A
Prodite Pharma (PPMD) - 0.08M - 0 -60
Gliatech (GLIAQ) - 0M - N/A N/A
SCOLR Pharma (SCLR) - 0.04M - N/A N/A
Cellcyte Genetics (CCYG) - 0.21M - 50 0
Vitro Diagnostics (VODG) - 1.53M - 0 -21.05
Dyadic International (DYAI) - 43.1M - -1.42% -14.72%
Invo Bioscience (IVOB) - 38.83M - 1.85% -21.43%
MMRGlobal (MMRF) - 0.4M - 100% -86.67%
AtheroNova (AHROQ) - 0.04M - 0 -72.22
Neuro Hitech (NHPI) - 0M - 0 0
US Stem Cell (USRM) - 13.92M 0.53 7.69% 44.83%
IR Biosciences (IRBS) - 0M - 0 -100
Affymax (AFFY) - 1.89M - -1.96% -26.47%
BioForce Nanosciences (BFNH) - 2.87M - 3.64% 776.92%
BioTime (BTX) - 329.3M 2.97 -2.62% -1%
Palatin Technologies (PTN) - 68.76M - 3.45% -21.33%
Genitope (GTOPQ) - 0.06M - 0 0
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Marina Biotech (MRNA) - 33.45M 16.75 -5.56% 148.18%
Nanobac Pharma (NNBP) - 0.4M - 0 0
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
ARYx Therapeutics (ARYX) - 0.1M - 50% -25%
Bellus Health (BLUSF) - 20.06M - -5.66% 69.49%
Oncolytics Biotech (ONCYF) - 54.15M - -8.47% 26.71%
Protalix Biotherapeutics (PLX) - 93.61M - -7.5% 15.63%
Rexahn Pharma (RNN) - 64.59M - -3.81% -12.29%
Health Discovery (HDVY) - 1.9M - 16.67% -81.58%
VIA Pharma (VIAP) - 0.1M - 0 66.67
NeurogesX (NGSX) - 0.17M - N/A N/A
Dendreon (DNDNQ) - 5.4M - N/A N/A
HedgePath Pharma (HPPI) - 121.97M - 0 42.86
Myrexis (MYRX) - 2.8M - 28.57% 47.27%
Pfenex (PFNX) - 111.18M 33.67 3.04% -39%
Atara Bio (ATRA) - 465.75M - 1.59% -28.64%
Interleukin Genetics (ILIU) - 2.8M - 20% -88%
Insite Vision (INSV) - 45.85M - N/A N/A
Addex Therapeutics (ADDXF) - 31.62M - 0 -11.32
Synthetic Biologics (SYN) - 66.43M - 0.58% -69.41%
Avax Technologies (AVXT) - 2.07M - 0 -50
Immune Therapeutics (IMUN) - 13.69M - -13.46% -73.53%
Biocurex (BOCX) - 0M - N/A N/A
Panacos Pharma (PANC) - 0.01M - 0 0
Protein Polymer (PPTIQ) - 0.06M - 0 0
Wowi (WOWU) - 9.73B - 39.44% 250%
Genmab (GNMSF) - 13.67B - 4.18% 32.33%
Viralytics (VRACY) - 183.42M - 0 4.09
Cormedix (CRMD) - 24.46M - 5.64% -73.25%
GeneLink (GNLKQ) - 0.37M - 0 0
Nicox (NICXF) - 330.94M - 0 3.94
Nutra Pharma (NPHC) - 0.57M - 100% -80%
ImmunoCellular Therapeutics (IMUC) - 1.32M - -68.85% -95.43%
Accentia BioPharma (ABPI) - 0.01M - N/A N/A
International Stem Cell Corp (ISCO) - 4.93M 5.81 -1.6% -36.76%
Theratechnologies (THERF) - 439.84M - 2.17% 205%
Capstone Therapeutics Corp. (CAPS) - 2.7M - -5.71% -5.71%
Pathfinder Cell (PFND) - 2.07M - 0 50
Provectus Biopharma (PVCT) - 11.11M - -3.23% -90.32%
Regenicin (RGIN) - 12.28M - 6.67% 280.95%
Guangzhou Pharma (GZPHY) - 639.8M - 0 -11.98
ZYTO Corp (ZYTO) - 0.91M - -56.67% -35%
Clovis Oncology (CLVS) - 4.22B - -2.51% 510.57%
Volitionrx (VNRX) - 81.72M - -3.13% -4.62%
Deltagen (DGEN) - 0M - 0 -100
Helix Biomedix (HXBM) - 7.85M - 0 0.21
IOVANCE BIOTHPT (IOVA) - 395.93M - 1.6% -11.19%
USA Equities Corp (USAQ) - 0.54M - 0 22.95
PROTAGENIC THER (PTIX) - 20.52M - 0 -56.88
Arbutus Biopharma (ABUS)
- 209.09M - 0 -9.52